AU2002316577A1 - Cell-screening assay and composition - Google Patents

Cell-screening assay and composition

Info

Publication number: AU2002316577A1
Authority: AU; Australia
Prior art keywords: cell; composition; screening assay; assay; screening
Prior art date: 2001-07-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002316577A

Inventor

Po-Ying Chan-Hui

Sharat Singh

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Monogram Biosciences Inc

Original Assignee

Aclara Biosciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-09

Filing date

2002-07-05

Publication date

2003-01-29

2002-07-05 Application filed by Aclara Biosciences Inc filed Critical Aclara Biosciences Inc

2003-01-29 Publication of AU2002316577A1 publication Critical patent/AU2002316577A1/en

Status Abandoned legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Hematology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
General Health & Medical Sciences (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2002316577A 2001-07-09 2002-07-05 Cell-screening assay and composition Abandoned AU2002316577A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US30429601P	2001-07-09	2001-07-09
US60/304,296		2001-07-09
US32529201P	2001-09-27	2001-09-27
US60/325,292		2001-09-27
PCT/US2002/021339 WO2003006947A2 (en)	2001-07-09	2002-07-05	Cell-screening assay and composition

Publications (1)

Publication Number	Publication Date
AU2002316577A1 true AU2002316577A1 (en)	2003-01-29

Family

ID=26973933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002316577A Abandoned AU2002316577A1 (en)	2001-07-09	2002-07-05	Cell-screening assay and composition

Country Status (2)

Country	Link
AU (1)	AU2002316577A1 (en)
WO (1)	WO2003006947A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040229294A1 (en)	2002-05-21	2004-11-18	Po-Ying Chan-Hui	ErbB surface receptor complexes as biomarkers
AU2004225439A1 (en)	2003-04-01	2004-10-14	Monogram Biosciences, Inc.	Intracellular complexes as biomarkers
US10416162B2 (en)	2007-12-20	2019-09-17	Monogram Biosciences, Inc.	Her2 diagnostic methods
ES2637411T3 (en)	2008-12-01	2017-10-13	Laboratory Corporation Of America Holdings	Methods and assays for measuring p95 Y / O p95 in a sample and antibodies specific for p95
SG172983A1 (en)	2009-01-15	2011-08-29	Lab Corp America Holdings	Methods of determining patient response by measurement of her-3
WO2013138585A1 (en) *	2012-03-16	2013-09-19	The Broad Institute, Inc.	Multiplex methods to assay mixed cell populations simultaneously
WO2014053479A1 (en)	2012-10-02	2014-04-10	Roche Diagnostics Gmbh	Methods of specifically releasing a sub-group of objects
CN108780089B (en)	2016-03-15	2020-09-08	美国控股实验室公司	Method for evaluating protein interactions between cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4725535A (en) *	1983-02-22	1988-02-16	Sonenshein Abraham L	Promoter probe vectors
US5658736A (en) *	1996-01-16	1997-08-19	Genetics Institute, Inc.	Oligonucleotide population preparation

2002
- 2002-07-05 AU AU2002316577A patent/AU2002316577A1/en not_active Abandoned
- 2002-07-05 WO PCT/US2002/021339 patent/WO2003006947A2/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2003006947A3 (en)	2003-05-08
WO2003006947A2 (en)	2003-01-23

Publication	Publication Date	Title
AU2002315389A1 (en)	2003-01-08	Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002357119A1 (en)	2003-06-30	Mitocidal compositions and methods
AU2001294814A1 (en)	2002-04-08	Pumpcn compositions and uses thereof
AU2002334307A1 (en)	2003-03-18	Novel lna compositions and uses thereof
AU2002350105A1 (en)	2003-01-08	Novel quinazolines and uses thereof
EP1247815A3 (en)	2003-01-29	Modified oligonucleotides and uses thereof
AU2002315388A1 (en)	2003-01-08	Novel phenylamino-pyrimidines and uses thereof
AU2002359392A1 (en)	2003-05-26	Rapid prion-detection assay
AU2002353861A1 (en)	2003-05-12	Assay
AU2002241114A1 (en)	2002-10-08	Composition
AU2002324450A1 (en)	2003-01-08	Novel pyridopyrimidines and uses thereof
AU2002357748A1 (en)	2003-06-10	Osteopontin-related compositions and methods
AU2002307031A1 (en)	2002-10-15	Thrombospondin-2 and uses thereof
AU2002316577A1 (en)	2003-01-29	Cell-screening assay and composition
AUPR446801A0 (en)	2001-05-17	Novel compositions and uses therefor
AU2002251543A1 (en)	2003-04-17	Novel atisane compound and use thereof
AU5240901A (en)	2001-11-20	Assay
AU2002359869A1 (en)	2003-07-24	Pak5-related compositions and methods
AU2002349088A1 (en)	2003-03-24	Compositions and methods for AA4RP assay
AU2002312558A1 (en)	2003-01-08	Novel pyridopyrimidones and uses thereof
AU2002322287A1 (en)	2003-01-08	Novel idolinones and uses thereof
AUPR369101A0 (en)	2001-04-12	Compositions and uses therefor - iv
AUPR369201A0 (en)	2001-04-12	Compositions and uses therefor - i
AUPR369001A0 (en)	2001-04-12	Compositions and uses therefor - iii
AUPR368901A0 (en)	2001-04-12	Compositions and uses therefor-ii

Legal Events

Date	Code	Title	Description
2004-04-08	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase